Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration.
Teo KYC, Eldem B, Joussen A, Koh A, Korobelnik JF, Li X, Loewenstein A, Lövestam-Adrian M, Navarro R, Okada AA, Pearce I, Rodríguez F, Wong D, Wu L, Zur D, Zarranz-Ventura J, Mitchell P, Chaudhary V, Lanzetta P. Teo KYC, et al. Among authors: zarranz ventura j. Eye (Lond). 2024 Oct 8. doi: 10.1038/s41433-024-03370-0. Online ahead of print. Eye (Lond). 2024. PMID: 39379523 Review.
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.
Puzo M, Calvo-Perez P, Bartol-Puyal F, Sanchez-Monroy J, Martin-Pinardel R, Parrado-Carrillo A, Moll-Udina A, Bernal-Morales C, Sanchez-Vela L, Sararols-Ramsay L, Garay-Aramburu G, Arruabarrena C, García-Arumí J, Abraldes M, Ruiz-Moreno JM, Valldeperas X, Velázquez-Villoria D, Escobar-Barranco JJ, Gallego-Pinazo R, Figueroa MS, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Puzo M, et al. Among authors: zarranz ventura j. Eye (Lond). 2024 Dec;38(18):3450-3458. doi: 10.1038/s41433-024-03322-8. Epub 2024 Sep 21. Eye (Lond). 2024. PMID: 39306616
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V; Fight Retinal Blindness! Study Group. Debourdeau E, et al. Ophthalmol Ther. 2024 Sep;13(9):2343-2355. doi: 10.1007/s40123-024-00983-2. Epub 2024 Jul 8. Ophthalmol Ther. 2024. PMID: 38976148 Free PMC article.
Correction: Díaz-Aljaro et al. Quantitative Microvascular Change Analysis Using a Semi-Automated Algorithm in Macula-on Rhegmatogenous Retinal Detachment Assessed by Swept-Source Optical Coherence Tomography Angiography. Diagnostics 2024, 14, 750.
Díaz-Aljaro P, Valldeperas X, Broc-Iturralde L, Romanic-Bubalo N, Díaz-Aljaro I, Chu Z, Wang RK, Zarranz-Ventura J. Díaz-Aljaro P, et al. Among authors: zarranz ventura j. Diagnostics (Basel). 2024 May 27;14(11):1107. doi: 10.3390/diagnostics14111107. Diagnostics (Basel). 2024. PMID: 38893733 Free PMC article.
Quantitative Microvascular Change Analysis Using a Semi-Automated Software in Macula-off Rhegmatogenous Retinal Detachment Assessed by Swept-Source Optical Coherence Tomography Angiography.
Díaz-Aljaro P, Zarranz-Ventura J, Broc-Iturralde L, Romanic-Bubalo N, Díaz-Aljaro I, Chu Z, Wang RK, Valldeperas X. Díaz-Aljaro P, et al. Among authors: zarranz ventura j. J Clin Med. 2024 May 11;13(10):2835. doi: 10.3390/jcm13102835. J Clin Med. 2024. PMID: 38792378 Free PMC article.
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!
Alforja S, Hunt A, Nguyen V, O'Toole L, Gabrielle PH, Invernizzi A, Mehta H, Ponsioen TL, Squirrell D, Casaroli-Marano RP, Barthelmes D, Gillies MC, Zarranz-Ventura J; Fight Retinal Blindness (FRB) users group. Alforja S, et al. Among authors: zarranz ventura j. Ophthalmol Retina. 2024 Oct;8(10):962-970. doi: 10.1016/j.oret.2024.04.014. Epub 2024 Apr 18. Ophthalmol Retina. 2024. PMID: 38641007
C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration.
Giralt L, Figueras-Roca M, Eguileor BL, Romero B, Zarranz-Ventura J, Alforja S, Santiago F, Bolaños J, Lozano F, Dotti-Boada M, Sala-Puigdollers A, Dura P, Izquierdo-Serra J, Valero O, Adan A, Fonollosa A, Molins B. Giralt L, et al. Among authors: zarranz ventura j. Front Immunol. 2024 Apr 3;15:1330913. doi: 10.3389/fimmu.2024.1330913. eCollection 2024. Front Immunol. 2024. PMID: 38633250 Free PMC article.
Quantitative Microvascular Change Analysis Using a Semi-Automated Algorithm in Macula-on Rhegmatogenous Retinal Detachment Assessed by Swept-Source Optical Coherence Tomography Angiography.
Díaz-Aljaro P, Valldeperas X, Broc-Iturralde L, Romanic-Bubalo N, Díaz-Aljaro I, Chu Z, Wang RK, Zarranz-Ventura J. Díaz-Aljaro P, et al. Among authors: zarranz ventura j. Diagnostics (Basel). 2024 Apr 1;14(7):750. doi: 10.3390/diagnostics14070750. Diagnostics (Basel). 2024. PMID: 38611663 Free PMC article.
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry.
Garay-Aramburu G, Hunt A, Arruabarrena C, Mehta H, Invernizzi A, Gabrielle PH, Guillaumie T, Wolff B, Gillies MC, Zarranz-Ventura J. Garay-Aramburu G, et al. Among authors: zarranz ventura j. Sci Rep. 2024 Mar 13;14(1):6122. doi: 10.1038/s41598-024-56581-6. Sci Rep. 2024. PMID: 38480837 Free PMC article.
110 results